Chronic pyrocellular leukemia is considered clinically “the luckiest leukaemia”, but there are still a number of problems that need to be addressed in the treatment of slow-particle patients, of which the problem of drug substitution for slow-particle patients is of particular concern. Slow Pneumonia Friends write to the public: mbxb120
It is not a case that chronic particle-cell leukemia patients have been investigated at a rate of up to 24 per cent. Most of those who need to change their medication are due to such factors as failure of treatment and poor tolerance. It should be noted that drug substitution is not a “twice-of-the-twilight” programme, and that there are still a number of patients who, after choosing to change, continue to suffer from intrusive side effects or poor treatment. In other words, the drug change is simply an attempt to find a new way to control the situation, not a new “loose-free” treatment. The current clinical belief that it is possible to select a suitable and sustainable drug at the beginning of treatment has a positive impact on disease control and treatment responses for most patients and may lead to longer lifespans. Conversely, if patients remain unadapted to drugs, the overall disease control effects will be seriously affected. Therefore, it is recommended that patients with slow-scraps should focus on drug side effects during the treatment process and be actively involved in mitigating the effects of interventions so as not to affect the final treatment. In addition, patients are required to follow medical instructions to treat them to the extent possible to avoid the risk of slippage and under-commitment and to reduce the risk of drug resistance. In daily life, there is also food management and scientific protection to lay the foundations for a stable recovery of the patient’s condition! In the light of the above, for those suffering from chronic pyrocellular leukaemia, the drug is replaced in order to achieve better treatment for the patient and therefore there is no need to resist. However, after the change of medication, it is necessary to re-examine the situation on a regular basis and to monitor the changes, in the hope of improving the patient ‘ s life expectancy.
